Global Peripheral Intervention Drug-Eluting Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 15-Jan-2019
No. of pages: 116

Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.

Scope of the Report:

This report focuses on the Peripheral Intervention Drug-Eluting Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Peripheral Intervention Drug-Eluting Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Medtronic plc

- Boston Scientific Corporation

- Abbott Laboratories

- Cardinal Health

- B. Braun Melsungen AG

- Biosensors International Group Ltd.

- C.R. Bard, Inc.

- St. Jude Medical, Inc.

- The Lubrizol Corporation

- Terumo Corporation

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Plain Old Balloon Angioplasty (POBA)

- Percutaneous Transluminal Angioplasty (PTA)

Market Segment by Applications, can be divided into

- Drug-Eluting Balloons

- Drug-Eluting Stents

There are 15 Chapters to deeply display the global Peripheral Intervention Drug-Eluting Devices market.

Chapter 1, to describe Peripheral Intervention Drug-Eluting Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Peripheral Intervention Drug-Eluting Devices, with sales, revenue, and price of Peripheral Intervention Drug-Eluting Devices, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Peripheral Intervention Drug-Eluting Devices, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Peripheral Intervention Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Peripheral Intervention Drug-Eluting Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Peripheral Intervention Drug-Eluting Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Plain Old Balloon Angioplasty (POBA)
1.2.2 Percutaneous Transluminal Angioplasty (PTA)
1.3 Market Analysis by Applications
1.3.1 Drug-Eluting Balloons
1.3.2 Drug-Eluting Stents
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic plc
2.1.1 Business Overview
2.1.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cardinal Health
2.4.1 Business Overview
2.4.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 B. Braun Melsungen AG
2.5.1 Business Overview
2.5.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biosensors International Group Ltd.
2.6.1 Business Overview
2.6.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 C.R. Bard, Inc.
2.7.1 Business Overview
2.7.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 St. Jude Medical, Inc.
2.8.1 Business Overview
2.8.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 The Lubrizol Corporation
2.9.1 Business Overview
2.9.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Terumo Corporation
2.10.1 Business Overview
2.10.2 Peripheral Intervention Drug-Eluting Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Peripheral Intervention Drug-Eluting Devices Market Analysis by Regions
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.5 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5 North America Peripheral Intervention Drug-Eluting Devices by Countries
5.1 North America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.3 Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6 Europe Peripheral Intervention Drug-Eluting Devices by Countries
6.1 Europe Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.3 UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.4 France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.5 Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
6.6 Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Peripheral Intervention Drug-Eluting Devices by Countries
7.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.3 Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.4 Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.5 India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8 South America Peripheral Intervention Drug-Eluting Devices by Countries
8.1 South America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Peripheral Intervention Drug-Eluting Devices by Countries
9.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.3 UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
10 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Type
10.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018)
10.2 Plain Old Balloon Angioplasty (POBA) Sales Growth and Price
10.2.1 Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018)
10.2.2 Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018)
10.3 Percutaneous Transluminal Angioplasty (PTA) Sales Growth and Price
10.3.1 Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018)
10.3.2 Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018)
11 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Application
11.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2013-2018)
11.2 Drug-Eluting Balloons Sales Growth (2013-2018)
11.3 Drug-Eluting Stents Sales Growth (2013-2018)
12 Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.4 South America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
12.3 Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2018-2023)
12.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023)
12.4 Peripheral Intervention Drug-Eluting Devices Market Forecast by Application (2018-2023)
12.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Peripheral Intervention Drug-Eluting Devices Picture
Table Product Specifications of Peripheral Intervention Drug-Eluting Devices
Figure Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Types in 2017
Table Peripheral Intervention Drug-Eluting Devices Types for Major Manufacturers
Figure Plain Old Balloon Angioplasty (POBA) Picture
Figure Percutaneous Transluminal Angioplasty (PTA) Picture
Figure Peripheral Intervention Drug-Eluting Devices Sales Market Share by Applications in 2017
Figure Drug-Eluting Balloons Picture
Figure Drug-Eluting Stents Picture
Figure United States Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure France Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure UK Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure China Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure India Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023)
Table Medtronic plc Basic Information, Manufacturing Base and Competitors
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cardinal Health Basic Information, Manufacturing Base and Competitors
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Type and Applications
Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors
Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors
Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table St. Jude Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications
Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2016-2017)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2017
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2016-2017)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2017
Figure Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017
Figure Global Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Regions (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Regions (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2013
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2017
Figure North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2013
Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table North America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2016
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries 2017
Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries 2017
Figure China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table South America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2013-2018)
Figure Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018)
Figure Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018)
Figure Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018)
Figure Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2013-2018)
Figure Global Drug-Eluting Stents Sales Growth (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Regions (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Regions (2018-2023)
Figure North America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Europe Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Asia-Pacific Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure South America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Figure Middle East and Africa Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Single Lead ECG Equipment Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 165
    Single lead ECG equipment is an device requires few basic actions to be operated and it is able to send transparently the acquired ECG to the designated service centre exploiting a Bluetooth connection with an Internet gateway. Application of single lead technology for monitoring heart rate during exercise, sports activities, and workout is projected to boost the adoption of these devices. According to this study, over the next five years the Single Lead ECG Equipment marke......
  • Global Seasonal Affective Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 139
    Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety. According to this study, over the next five years the Seasonal Affective Disorder Therapeutics market will register a x......
  • Global Circadian Rhythm Sleep Treatment Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 137
    A circadian rhythm is any biological process that displays an endogenous, entrainable oscillation of about 24 hours. These 24-hour rhythms are driven by a circadian clock, and they have been widely observed in plants, animals, fungi, and cyanobacteria. Circadian rhythm sleep treatment follows two pathways, which include utilizing drug therapy or light therapy that involves the usage of certain devices. According to this study, over the next five years the Circadian Rhythm Sleep Tr......
  • Global PET-CT Systems Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 165
    Positron emission tomography-computed tomography (better known as PET-CT or PET/CT) is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, to acquire sequential images from both devices in the same session, which are combined into a single superposed (co-registered) image. Thus, functional imaging obtained by PET, which depicts the spatial distribution of metabolic or biochemical activity in ......
  • Global Medical Baby Monitoring Devices Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 160
    Medical Baby Monitoring Devices, also called baby monitor, is an electronic device that belonging to the home security system for active babies sleep quality testing and so on. According to this study, over the next five years the Medical Baby Monitoring Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of......
  • Global Natural Cold, Cough, and Sore Throat Remedies Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 118
    Medication for the treatment of cold, cough, and sore throat derived from natural substances fall under the purview of natural cold, cough, and sore throat remedies. According to this study, over the next five years the Natural Cold, Cough, and Sore Throat Remedies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key comp......
  • Global Auto Lensometer Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 163
    Auto Lensometer as a focimeter or vertometer, is an ophthalmic instrument. It is mainly used by optometrists and opticians to verify the correct prescription in a pair of eyeglasses, to properly orient and mark uncut lenses, and to confirm the correct mounting of lenses in spectacle frames. Lensmeters can also verify the power of contact lenses, if a special lens support is used. According to this study, over the next five years the Auto Lensometer market will register a xx% CAGR ......
  • Global Manual Lensmeter Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 135
    Manual Lensmeter as a focimeter or vertometer, is an ophthalmic instrument. It is mainly used by optometrists and opticians to verify the correct prescription in a pair of eyeglasses, to properly orient and mark uncut lenses, and to confirm the correct mounting of lenses in spectacle frames. Lensmeters can also verify the power of contact lenses, if a special lens support is used. According to this study, over the next five years the Manual Lensmeter market will register a xx% CAG......
  • Global Photodynamic Therapy Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Photodynamic Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Photodynamic Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Photodynamic Therapy market by pr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs